...
首页> 外文期刊>Molecular Immunology >Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57
【24h】

Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57

机译:抗狂犬病G蛋白单链抗体可变片段FV57中二硫键错配的负面影响

获取原文
获取原文并翻译 | 示例
           

摘要

Rabies virus (RV) causes a fatal infectious disease requiring efficient post-exposure prophylaxis (PEP), which includes a rabies vaccine and rabies immunoglobulin (RIG). The single-chain antibody variable fragment (scFv), a small engineered antibody fragment derived from an antibody variable heavy chain and light chain, has the potential to replace the current application of RIG. In previous studies, we constructed and evaluated an anti-rabies virus G protein scFv (FV57) based on the monoclonal antibody CR57. Of the five cysteines in FV57, four are linked in intra-chain disulfide bonds (Cys-VH28/Cys-VH98 and Cys-VL16/Cys-VL84), and one is free (Cys-VL85). However, the thiol in Cys-VL85 neighboring Cys-VL84 in the CDR3 of the light chain is likely to mismatch with the thiol in Cys-VL16 during the renaturing process. In order to study effects of the mismatched disulfide bond, Cys-VL85 and Cys-VL84 of FV57 were mutated to serine to construct mutants FV57VL85S and FV57VL84S. Furthermore, the disulfide bonds in the light chain of FV57, FV57VL85S and FV57VL84S were deleted by mutating Cys-VL16 to serine. All mutants were prepared and evaluated along with the original FV57. The results indicated that the mismatched disulfide bond of FV57 linking the light chain FR1 and CDR3 would confer deleterious negative effects on its activity against RV, likely due to spatial hindrance in the light chain CDR3. Moreover, avoidance of the disulfide bond mismatch provided an additional 30% protective efficacy against RV infection in the mouse RV challenge model. Thus, modifications of FV57 to eliminate the disulfide bond mismatch may provide a candidate therapeutic agent for effective PEP against rabies.
机译:狂犬病病毒(RV)导致致命的传染病,需要有效的暴露后预防(PEP),其中包括狂犬病疫苗和狂犬病免疫球蛋白(RIG)。单链抗体可变片段(scFv)是衍生自抗体可变重链和轻链的小型工程化抗体片段,具有取代RIG当前应用的潜力。在以前的研究中,我们基于单克隆抗体CR57构建和评估了抗狂犬病病毒G蛋白scFv(FV57)。 FV57中的五个半胱氨酸中,四个以链内二硫键连接(Cys-VH28 / Cys-VH98和Cys-VL16 / Cys-VL84),一个是游离的(Cys-VL85)。但是,轻链CDR3中与Cys-VL84相邻的Cys-VL85中的硫醇可能在复性过程中与Cys-VL16中的硫醇错配。为了研究错配的二硫键的作用,将FV57的Cys-VL85和Cys-VL84突变为丝氨酸,以构建突变体FV57VL85S和FV57VL84S。此外,通过将Cys-VL16突变为丝氨酸,FV57,FV57VL85S和FV57VL84S的轻链中的二硫键被缺失。制备所有突变体并与原始FV57一起评估。结果表明,连接轻链FR1和CDR3的FV57的二硫键不匹配,可能对RV的活性产生有害的负面影响,这可能是由于轻链CDR3的空间障碍。此外,在小鼠RV激发模型中,避免二硫键错配可额外提供30%的抗RV感染保护作用。因此,FV57的修饰以消除二硫键错配可以为有效的针对狂犬病的PEP提供候选治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号